Delivery Order SPE2DB22D3401-SPE2DB24FT4NP

Award Date 9/5/24
Potential Completion Date 9/6/24
Potential Value $4.1K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,118.90 contract is for the delivery of XELJANZ XR 11 MG TABLET UU 30S, a prescription medication. The contract has an ultimate completion date of January 10, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp Corporate Office Division, a major pharmaceutical distributor, for the supply of XELJANZ XR 11 MG TABLET UU 30S. The $4,522.05 firm-fixed-price contract has an ultimate completion date of August 2, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 through December 2025, which enables the DLA Troop Support Medical to efficiently...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $12,204.71, is for the supply of XELJANZ XR 11 MG TABLET UU 30S, a pharmaceutical product. The delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical, which serves as a...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of XELJANZ XR 11 MG TABLET, a prescription medication. The firm-fixed-price delivery order, valued at $22,912.52, has an ultimate completion date of August 22, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued up to $999,999,999 through December...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical distribution company. The order is for 4,563,802,810 units of the prescription medication XELJANZ XR 11 MG TABLET, with a potential value of $21,480.81 and a completion date of February 29, 2024. This delivery order is part of a larger indefinite delivery contract (IDC)...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of XELJANZ XR 11 MG TABLET UU 30S. The contract has a firm fixed price of $17,853.88 and an ultimate completion date of September 10, 2024. This award is a part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for delivering a...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of XELJANZ XR 11 MG TABLET 30S. The $7,896.21 firm fixed-price contract has a completion date of September 12, 2024. This order is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for the provision of a comprehensive range of...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, for the supply of XELJANZ XR 11 MG TABLET. The award has a firm fixed price ceiling value of $5,901.13 and an ultimate completion date of August 30, 2024. This delivery order is placed under a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,702.43, is for the delivery of XELJANZ XR 11 MG TABLET UU 30S. It is a firm fixed price contract with a completion date of January 6, 2025. The contract is not designated as a set-aside. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC)...
The U.S. government agency Defense Logistics Agency (DLA) awarded a delivery order contract worth $1,507.35 to the Amerisourcebergen Drug Corp's Corporate Office Division, a major pharmaceutical distribution company. The contract is for the delivery of XELJANZ XR 11 MG TABLET UU 30S, a prescription medication, with a performance period ending on May 8, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that Amerisourcebergen holds...
  • SPE2DB22D3401
    Indefinite Delivery Contract
  • SPE2DB22D3401-SPE2DB24FT4NP
    Delivery Order

This is a federal delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $4,118.34, is for the supply of XELJANZ XR 11 MG TABLET UU 30S, a prescription medication. The delivery order is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA, valued at up to $999,999,999, to provide a comprehensive range of medical commodities to support military treatment programs and facilities worldwide. This contract has no set-aside designation and is expected to be completed by September 6, 2024.

Generated 12/5/24, 10:23 AM